EcoDrugPlus

Ensembl ID : ENSCSAVG00000008984
Gene Symbol: -
1 Cross references
223 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009215
Gene Symbol: -
1 Cross references
1092 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009491
Gene Symbol: -
1 Cross references
750 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009533
Gene Symbol: -
1 Cross references
331 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009638
Gene Symbol: -
1 Cross references
206 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009689
Gene Symbol: -
1 Cross references
485 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009693
Gene Symbol: -
1 Cross references
294 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009699
Gene Symbol: -
1 Cross references
206 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009717
Gene Symbol: -
1 Cross references
491 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009747
Gene Symbol: -
1 Cross references
269 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009788
Gene Symbol: -
1 Cross references
665 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009911
Gene Symbol: -
1 Cross references
291 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).